NASDAQ · Price History

Braveheart Bio, Inc. (BRVE) Stock Price History & Returns

$18.78 NASDAQ: BRVE Market Cap $1.33B

Price history through Nov 17, 2026 · Source: Yahoo Finance (adjusted closes) (methodology)

How Braveheart Bio, Inc. (BRVE) has performed, year by year and over each trailing period. Price history only — total return to a shareholder would also include dividends.

The share price of $18.78 sits 14% of the way up a 52-week range of $16.70 to $32.00; 41.3% below the 52-week high; below its 50-day moving average of $21.93; below its 200-day average of $23.56; a beta of 0.00 means it has historically moved less than the market.

Total return

Price change over each trailing period, not annualised.

PeriodReturn
3 months-35.2%

Monthly closing prices

The last 4 months, newest first. 1 of 3 months closed higher than the month before. Each figure is the last close in that month.

MonthCloseChange
November 2026$18.78-12.9%
October 2026$21.57+7.4%
September 2026$20.08-20.9%
August 2026$25.38—

Braveheart Bio, Inc. (BRVE) price history — frequently asked questions

How has Braveheart Bio, Inc. performed over the last year?

Braveheart Bio, Inc. (BRVE) has risen 0.0% over the last twelve months, measured on price alone.

What is Braveheart Bio, Inc.'s five-year return?

Over five years the BRVE share price has gained 0.0%, excluding dividends.

What is Braveheart Bio, Inc.'s 52-week range?

Over the last year Braveheart Bio, Inc. (BRVE) has traded between $16.70 and $32.00.

Price returns of other Biotechnology stocks

VRTX 1-year +22.4%REGN 1-year +38.2%MRNA 1-year +740.3%RVMD 1-year +137.0%ROIV 1-year +92.3%INSM 1-year -36.3%UTHR 1-year +27.9%INCY 1-year +14.8%ALNY 1-year -63.6%ASND 1-year +33.4%All Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.